Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals

United States News News

Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals
United States Latest News,United States Headlines
  • 📰 NPR
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 63%

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.

British pharmaceutical firm that makes asthma inhalers. An office of the company is seen here in Neuchatel, western Switzerland.Fabrice Coffrini/AFP via Getty Images

The maker of Marlboro cigarettes is selling Vectura to Molex Asia Holdings Ltd., which plans to operate the inhaler business as part of its Phillips Medisize unit, which produces drugs and medical devices.The two-part sale includes an upfront cash payment of 150 million pounds sterling — around $200 million, at Friday’s exchange rate. The deal also calls for “potential deferred payments” of a second, nearly equal amount.

That information was derided by health groups in the U.K., where Vectura is based — many of whom had protested the cigarette maker’s acquisition of the asthma inhaler company. Critics of the deal noted that Philip Morris was taking over a business that made the lion’s share of its hundreds of millions of dollars in annual revenue from products meant to treat smoking-related respiratory illnesses, such as chronic obstructive pulmonary disease.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NPR /  🏆 96. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goalsPhilip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goalsThree years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.
Read more »

Philip Morris to invest $232 million to expand ZYN production at Kentucky plantPhilip Morris to invest $232 million to expand ZYN production at Kentucky plantReuters
Read more »

Opinion: Giving Philip Morris $16 million in tax incentives ignores Big Tobacco’s public health impactOpinion: Giving Philip Morris $16 million in tax incentives ignores Big Tobacco’s public health impactThe deal for Philip Morris International to open a nicotine pouch manufacturing facility in Aurora is a miss for public health in Colorado
Read more »

Philip Morris International is expanding Kentucky factory to boost production of nicotine pouchesPhilip Morris International is expanding Kentucky factory to boost production of nicotine pouchesPhilip Morris International on Tuesday announced a $232 million expansion at a Kentucky factory to boost production of nicotine pouches tied to its
Read more »

Philip Morris International is expanding Kentucky factory to boost production of nicotine pouchesPhilip Morris International is expanding Kentucky factory to boost production of nicotine pouchesPhilip Morris International has announced a $232 million factory expansion in Kentucky. The expansion will boost production of nicotine pouches that the company says are part of its strategy for a “smoke-free future.” The dissolvable pouches fit between a person's lip and gums to slowly release nicotine.
Read more »

New Blockbuster Three-Team Trade Proposal Forms New Big Three, Durant Heads To ATLNew Blockbuster Three-Team Trade Proposal Forms New Big Three, Durant Heads To ATLCould the Hawks pull off a blockbuster move by trading for Kevin Durant - and make themselves into Eastern Conference contenders?
Read more »



Render Time: 2025-04-07 21:17:22